Authors
M. Frances Wright, MD
Resident Physician
Austin Turner, MD
Hematopathology Fellow
Ridas Juskevicius, MD
Assistant Professorr
Mary Ann Thompson, MD, PhD
Associate Professorr
Department of Pathology, Microbiology, and Immunology
Vanderbilt University Medical Center
Nashville, Tennessee
Primary Audience: Pathologists and Clinical Scientists
Secondary Audience: Residents, Laboratory Technologist/Scientist (Includes all sub-specialty areas), Students, Pathologist Assistants, Laboratory Directors and Educators
Upon completion of this activity, you will be able to:
- choose the immunohistochemical and molecular tests that would best evaluate a skin biopsy specimen from a patient at risk for hydroa vacciniforme-like lymphoproliferative disorder (HV-LPD);
- evaluate where on the spectrum of HV-LPD a patient may fall based on clinicopathologic and laboratory findings;
- compare the clinicopathologic characteristics and histopathologic findings of cutaneous lymphomas in the differential diagnosis of HV-LPD; and
- evaluate treatment considerations for a patient with HV-LPD based on severity of disease and presence or absence of hemophagocytic syndrome.